Allué, José Antonio
Araclon Biotech Ltd. Zaragoza Spain
3 papers on CoChatORCID 0000-0002-5690-3618
Most cited papers
- Verified
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
Janelidze, S., Teunissen, C. E., Zetterberg, H., Allué, J. A., Sarasa, L., Eichenlaub, U., Bittner, T., Ovod, V., Verberk, I. M. W., Toba, K., et al. (2021) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 494
- Verified
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau
Janelidze, S., Palmqvist, S., Leuzy, A., Stomrud, E., Verberk, I. M. W., Zetterberg, H., Ashton, N. J., Pesini, P., Sarasa, L., Allué, J. A., et al. (2022) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 188
- Verified
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations
Cullen, N. C., Leuzy, A., Palmqvist, S., Janelidze, S., Stomrud, E., Pesini, P., Sarasa, L., Allué, J. A., Proctor, N. K., Zetterberg, H., et al. (2020) · Nature Aging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 187
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free